Extra-osseous Ewing's sarcoma

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
Phase II/III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II/III

1 trial
  • The University Of Birmingham Academic
    LENVATINIB
    2024-516078-31-00 10 countries 2015 n=436
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
The University Of Birmingham Academic 1 Phase II/III 1
← All indication landscapes